Showing results (601-610 of 844) with videos related to

Sort By:
Pageof 85
Pediatrics|January 17, 2024
Learning From a National Quality Improvement Collaborative for Brief Resolved Unexplained EventsDaniela Hochreiter, Erin Sullivan, Amy M DeLaroche, et al.
Anti-Cancer Drugs|February 3, 2009
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic featuresAlessandra Balduzzi, Emilia Montagna, Vincenzo Bagnardi, et al.
Breast (Edinburgh, Scotland)|March 15, 2011
Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancerSilvia Dellapasqua, Manuelita Mazza, Debora Rosa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK)M M Borner, M Castiglione, M Bacchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to VMarco Colleoni, Zhuoxin Sun, Karen N Price, et al.
Breast (Edinburgh, Scotland)|August 16, 2006
Primary therapy with ECF in combination with a GnRH analog in premenopausal women with hormone receptor-positive T2-T4 breast cancerRosalba Torrisi, Marco Colleoni, Paolo Veronesi, et al.
British Journal of Cancer|August 23, 2007
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerR Torrisi, V Bagnardi, G Pruneri, et al.
Clinical Breast Cancer|November 5, 2013
Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastasesSilvia Dellapasqua, Vincenzo Bagnardi, Alessandra Balduzzi, et al.
Cancer Letters|January 30, 2017
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trialEmilia Montagna, Antonella Palazzo, Patrick Maisonneuve, et al.
Breast (Edinburgh, Scotland)|May 6, 2008
Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancerLaura Orlando, Barbara Del Curto, Sara Gandini, et al.
Pageof 85